Skip to content
10-K

Annual Report

STEMLINE THERAPEUTICS INC

0001104659-19-015293

← back to feed
Filed
Mar 15, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2018 · Mar 15, 2019 43.57M sh
Net Income FY 2018 · Dec 31, 2018 −$300.8M
Net Income FY 2018 · Dec 31, 2017 −$21.75M
Net Income FY 2018 · Sep 30, 2017 −$16.06M
Net Income FY 2018 · Jun 30, 2017 −$15.46M
Net Income FY 2018 · Mar 31, 2017 −$14.57M
Net Income FY 2018 · Dec 31, 2016 −$38.3M
Revenue FY 2018 · Dec 31, 2018 $500K
Revenue FY 2018 · Dec 31, 2017 $898.2K
Revenue FY 2018 · Dec 31, 2016 $1.04M
Short Term Investments FY 2018 · Dec 31, 2017 $46.92M
Cash And Equivalents FY 2018 · Dec 31, 2017 $4.8M
Current Liabilities FY 2018 · Dec 31, 2017 $19.84M
Total Liabilities FY 2018 · Dec 31, 2017 $19.94M
Current Assets FY 2018 · Dec 31, 2017 $52.19M
Total Assets FY 2018 · Dec 31, 2017 $67.01M
Operating Cash Flow FY 2018 · Dec 31, 2016 −$30.09M
Rd Expense FY 2018 · Dec 31, 2016 $27.87M
Operating Income FY 2018 · Dec 31, 2016 −$38.89M
Stockholders Equity FY 2018 · Dec 31, 2015 $88.11M